|
|
Books > Medicine > Pre-clinical medicine: basic sciences > Medical genetics
From the gene that causes people to age prematurely to the "bitter
gene" that may spawn broccoli haters, this book explores a few of
the more exotic locales on the human genome, highlighting some of
the tragic and bizarre ways our bodies go wrong when genes fall
prey to mutation and the curious ways in which genes have evolved
for our survival. Lisa Seachrist Chiu offers here a smorgasbord of
stories about rare and not so rare genetic quirks-the gene that
makes some people smell like a fish, the Black Urine Gene, the
Werewolf Gene, the Calico Cat Gene. We read about the Dracula Gene,
a mutation in zebra fish that causes blood cells to explode on
contact with light, and suites of genes that also influence
behavior and physical characteristics. The Tangier Island Gene,
first discovered after physicians discovered a boy with orange
tonsils (scientists now realize that the child's odd condition
comes from an inability to process cholesterol). And Wilson's
Disease, a gene defect that fails to clear copper from the body,
which can trigger schizophrenia and other neurological symptoms,
and can be fatal if left untreated. On the plus side, we read about
the Myostatin gene, a mutation which allows muscles to become much
larger than usual and enhances strength-indeed, the mutations have
produced beefier cows and at least one stronger human. And there is
also the much-envied Cheeseburger Gene, which allows a lucky few to
eat virtually anything they want and remain razor thin. While
fascinating us with stories of genetic peculiarities, Chiu also
manages to explain much cutting-edge research in modern genetics,
resulting in a book that is both informative and entertaining. It
is a must read for everyone who loves popular science or is curious
about the human body.
Translational Systems Medicine and Oral Disease bridges the gap
between discovery science and clinical oral medicine, providing
opportunities for both the scientific and clinical communities to
understand how to apply recent findings in cell biology, genomic
profiling, and systems medicine to favorably impact the diagnosis,
treatment and management of oral diseases. Fully illustrated
chapters from leading international contributors explore clinical
applications of genomics, proteomics, metabolomics, microbiomics
and epigenetics, as well as analytic methods and functional omics
in oral medicine. Disease specific chapters detail systems
approaches to periodontal disease, salivary gland diseases, oral
cancer, bone disease, and autoimmune disease, among others. In
addition, the book emphasizes biological synergisms across
disciplines and their translational impact for clinicians,
researchers and students in the fields of dentistry, dermatology,
gastroenterology, otolaryngology, oncology and primary care.
This thesis demonstrates a technology that enables pipetting-free
high-throughput screening (HTS) on a miniaturized platform,
eliminating the need for thousands of one-by-one pipetting and
conventional liquid handling systems. This platform enhances
accessibility to HTS and enables HTS to be used in small-to-medium
scale laboratories. In addition, it allows large-scale
combinatorial screening with a small number of valuable cells, such
as patients' primary cancer cells. This technique will have a high
impact for widespread use of HTS in the era of personalized
medicine. In this thesis, the author firstly describes the need and
concept of 'partipetting' for pipetting-free HTS platform. It is
realized by the one-step pipetting and self-assembly of encoded
drug-laden microparticles (DLPs) on the microwells. Next, the
technical implementations required for the platform demonstration
are described. It includes preparation of encoded DLPs, plastic
chip fabrication, and realization of automated system. Lastly,
screening of sequential drug combinations using this platform is
demonstrated. This shows the potential of the proposed technology
for various applications.
Transgenerational Epigenetics, Second Edition, offers the only
up-to-date, comprehensive analysis of the inheritance of epigenetic
phenomena between generations with an emphasis on human disease
relevance, drug discovery, and next steps in clinical translation.
International experts discuss mechanisms of epigenetic inheritance,
its expression in animal and plant models, and how human ailments,
such as metabolic disorders and cardiovascular disease are
influenced by transgenerational epigenetic inheritance. Where
evidence is sufficient, epigenetic clinical interventions are
proposed that may help prevent or reduce the severity of disease
before offspring are born. This edition has been thoroughly revised
in each disease area, featuring newly researched actors in
epigenetic regulation, including long noncoding RNA in addition to
histone modifications and DNA methylation. Therapeutic pathways in
treating cancer and extending human longevity are also considered,
as are current debates and future directions for research.
Emery and Rimoin's Principles and Practice of Medical Genetics and
Genomics: Cardiovascular, Respiratory, and Gastrointestinal
Disorders, Seventh Edition includes the latest information on
seminal topics such as prenatal diagnosis, genome and exome
sequencing, public health genetics, genetic counseling, and
management and treatment strategies. This comprehensive, yet
practical, resource emphasizes theory and research fundamentals
relating to applications of medical genetics across the full
spectrum of inherited disorders and applications to medicine.
Updated sections in this release cover the genetics of
cardiovascular, respiratory and gastrointestinal disorders, with an
emphasis on genetic determinants and new pathways for diagnosis,
prevention and disease management. In addition, genetic
researchers, students and health professionals will find new and
fully revised chapters on the molecular genetics of congenital
heart defects, inherited cardiomyopathies, hypertension, cystic
fibrosis, asthma, hereditary pulmonary emphysema, inflammatory
bowel disease, and bile pigment metabolism disorders among other
conditions.
Obesity and diabetes develop as a complex result of genetic,
metabolic and environmental factors and are characterized by
increased lipogenesis and lipid accumulation in many tissues.
Stearoyl-CoA desaturase (SCD) genes are a critical regulator of
lipogenesis and catalyzes the synthesis of monounsaturated fatty
acids (MUFA), mainly oleoyl- (18:1n9) and palmitoleoyl-CoA
(16:1n7). These MUFAs are the major fatty acid substrates for the
synthesis of triglycerides, cholesterol esters, wax esters and
membrane phospholipids. There are 4 SCD isoforms (SCD1-4) in mice
and two (hSCD1 and hSCD5) expressed in humans. At first glance,
stearoyl-CoA desaturase enzyme would be considered a housekeeping
enzyme because it synthesizes oleate a well-known fatty acid that
is abundant in many dietary sources. However numerous studies have
shown that SCD is a very highly regulated enzyme that features in
so many physiological processes ranging from fat differentiation,
carbohydrate and fat metabolism, inflammation and cancer. The
editor's studies using stearoyl-CoA desaturase knockout (SCD1-/-)
mice and studies of other investigators using pharmacological
approaches to reduce SCD1 expression in mouse tissues have all
established that the expression of SCD1 gene isoform represents a
key step in partitioning of lipids between storage and oxidation.
High SCD expression favors fat storage leading to obesity while
reduced SCD expression favors fat burning and leanness. Although
these studies clearly illustrated that SCD1 expression is involved
in the development of obesity and insulin resistance, questions
remain in the elucidation of the mechanisms involved and role of
SCD1. This book includes chapters by leading researchers on SCD
Genes in the brain, heart, muscle, liver metabolism, Colitis, and
more.
miRNAs are a class of endogenous, small non-protein coding RNA
molecules (~ 22 nucleotides) which are novel post-transcriptional
regulators of gene expression. Since we have hundreds of miRNAs,
the major challenge is now to understand their specific biological
function. In fact the experimental evidence suggests that signaling
pathways could be ideal candidates for miRNA-mediated regulation.
Several studies suggest that miRNAs affect the responsiveness of
cells to signaling molecules such as WNT, Notch, TGF- and EGFR.
Altered expression of particular miRNAs has been implicated in the
onset and development of cancer and could be used as potential
biomarkers for the disease. Recently, many studies have found
miRNAs have crucial regulatory roles in Cancer stem cells (CSCs) a
kind of tumor initiating cells (TICs) and dormancy. Findings also
suggest that DNA methylation may be important in regulating the
expression of many miRNAs in several cancer initiating cells.
Several miRNAs are known to either upregulated or downregulated in
CSCs when compared to non-cancerous cells from the same tissues.
CSCs are a small subpopulation of cells identified in a variety of
tumors and involve in self-renewal, differentiation,
chemoresistance and tumorigenesis. The volume will give a
comprehensive account of important advancements in the area of
miRNAs and cancer.
The completion of the human genome project in 2000 dramatically
emphasized the imminent success of the genetic revolution. The
ethical and social consequences of this scientific development are
immense. From human reproduction to life-extending therapies, from
the impact on gender and race to public health and public safety,
there is scarcely a part of our lives left unaffected by the impact
of the new genetics. A Companion to Genethics is the first
substantial study of the multifaceted dimensions of the genetic
revolution and its philosophical, ethical, social, and political
significance. It brings together the best and most influential
contemporary writing about genethics. Newly commissioned essays
from prominent figures in the current debate provide a wide-ranging
and fascinating scholarly analysis of all the issues that arise
from this explosive science.
For decades, Emery and Rimoin's Principles and Practice of Medical
Genetics and Genomics has served as the ultimate resource for
clinicians integrating genetics into medical practice. With
detailed coverage in contributions from over 250 of the world's
most trusted authorities in medical genetics and a series of 11
volumes available for individual sale, the Seventh Edition of this
classic reference includes the latest information on seminal topics
such as prenatal diagnosis, genome and exome sequencing, public
health genetics, genetic counseling, and management and treatment
strategies to complete its coverage of this growing field for
medical students, residents, physicians, and researchers involved
in the care of patients with genetic conditions. This comprehensive
yet practical resource emphasizes theory and research fundamentals
related to applications of medical genetics across the full
spectrum of inherited disorders and applications to medicine more
broadly. Clinical Principles and Applications thoroughly addresses
general methods and approaches to genetic counseling, genetic
diagnostics, treatment pathways, and drug discovery. Additionally,
new and updated chapters explore the clinical implementation of
genomic technologies, analytics, and therapeutics, with special
attention paid to developing technologies, common challenges,
patient care, and ethical and legal aspects. With regular advances
in genomic technologies propelling precision medicine into the
clinic, the seventh edition of Emery and Rimoin's Principles and
Practice of Medical Genetics and Genomics bridges the gap between
high-level molecular genetics and practical application and serves
as an invaluable clinical tool for the health professionals and
researchers.
This detailed volume explores the notable progress in the field of
zinc finger proteins (ZFP) study through widely used methods and
protocols involving their biological functions and applications.
Beginning with a section on the basic biology of ZFPs and design
and applications of custom ZFPs, the book continues by covering
methods for the evaluation and prevention of ZFN-mediated
cytotoxicity as well as a collection of the representative methods
of ZFN delivery. Written for the highly successful Methods in
Molecular Biology series, chapters include introductions to their
respective topics, lists of the necessary materials and reagents,
step-by-step, readily reproducible laboratory protocols, and tips
on troubleshooting and avoiding known pitfalls. Authoritative and
practical, Zinc Finger Proteins: Methods and Protocols aims to
prompt both the understanding of ZFP biology and the development of
next-generation ZFP therapeutics.
This book looks at where stem cell technology is presently and how
it is instrumental in advancing the field of disease modeling and
cell transplantation. By focusing on major human disorders such as
Alzheimer's disease, cancer, and heart disorders, the book
summarizes the major findings in the field of human stem cells and
dissect the current limitations on our understanding of stem cells
biology. The chapters focus on the genetics, genomics, epigenetics
and physiology of stem cells models, together with technological
advances on molecular biology such as CRISPR/Cas9 or epigenetic
editing, that will be instrumental in the future of human disease
modeling and treatment. In base of the limitations of current
disease models and in front of the unmet necessity of finding
therapeutical interventions for human disorders, the availability
of stem cell technology has opened new doors for several fields.
The unlimited self-renewal capacity and more extensive
differentiation potential of stem cells offers a theoretically
inexhaustible and replenishable source of any cell subtype. Since
Professor Shinya Yamanaka described it, 10 years ago in his seminal
paper, that somatic cells could be reprogrammed to inducible stem
cells (iPSC) just by expressing four transcription factors, the
field of has exploded, especially its applications in biomedical
research.
Androgens are critical regulators of prostate differentiation
and function, as well as prostate cancer growth and survival.
Therefore, androgen ablation is the preferred systemic treatment
for disseminated prostate cancer. Androgen action is exerted in
target tissues via binding the androgen receptor (AR), a nuclear
receptor transcription factor.
Historically, the gene expression program mediated by the AR has
been poorly understood. However, recent gene expression profiling
and more traditional single-gene characterization studies have
revealed many androgen-regulated genes that are important mediators
of androgen action in both normal and malignant prostate tissue.
This book will focus on the androgen-regulated gene expression
program, and examine how recently identified androgen-regulated
genes are likely to contribute to the development and progression
of prostate cancer. Recent studies that have attempted to unravel
how these genes are deregulated in androgen depletion independent
prostate cancer will be included
Originally thought to be available only to the world's wealthiest
nations, genomic medicine has developed into a broad range of
clinical methods and technologies whose concrete applications are
also revolutionizing health systems in many of the world's
resource-limited nations. Genomic Medicine in Emerging Economies:
Genomics for Every Nation provides in-depth analysis and key
examples of the implementation of medical genomics in low-income
nations across the globe, demonstrating how this advancing medical
science has already transformed health systems and led to improved
patient care in Indonesian, Chilean, Malaysian, Argentinian,
Chinese, Sri Lankan, and Colombian populations among others. In
addition to defining tools, diagnostics, and treatment pathways at
the population-wide level for medical geneticists, genomic
researchers, and public health workers to apply in their own work,
this book offers an essential, case-study based approach needed to
understand how genomic medicine can be used to improve
disease-management in a diverse range of economic and social
contexts.
While technological advancements have been critical in allowing
researchers to obtain more and better quality data about cellular
processes and signals, the design and practical application of
computational models of genomic regulation continues to be a
challenge. Emerging Research in the Analysis and Modeling of Gene
Regulatory Networks presents a compilation of recent and emerging
research topics addressing the design and use of technology in the
study and simulation of genomic regulation. Exploring both
theoretical and practical topics, this publication is an essential
reference source for students, professionals, and researchers
working in the fields of genomics, molecular biology,
bioinformatics, and drug development.
This volume focuses on mitochondrial RNA metabolism, emphasizing
recent discoveries and technological advances in this fast moving
area that increase our understanding of mitochondrial gene
function. Topics addressed include the interplay of mitochondria
with the nucleus and cytosol, structure-function connections, and
relevance to human disease. Mitochondria are the powerhouses of the
cell, and a great deal is known about mitochondrial energy
metabolism. Less well known is the plethora of amazing mechanisms
that have evolved to control expression of mitochondrial genomes.
Several RNA processes and machineries in protozoa, plants, flies
and humans are discussed, including: transcription and RNA
polymerase mechanism; tRNA processing of 5' and 3' ends; mRNA
maturation by nucleotide insertion/deletion editing and by RNA
splicing; mRNA stability; and RNA import. Specialized factors and
ribonucleoproteins (RNPs) examined include pentatricopeptide repeat
(PPR) proteins, RNase P, polymerases, helicases, nucleases, editing
and repair enzymes. Remarkable features of these processes and
factors are either not found outside mitochondria, differ
substantially among eukaryotic lineages, or are unique in biology.
Human Reproductive and Prenatal Genetics presents the latest
material from a detailed molecular, cellular and translational
perspective. Considering its timeliness and potential international
impact, this all-inclusive and authoritative work is ideal for
researchers, students, and clinicians worldwide. Currently, there
are no comprehensive books covering the field of human reproductive
and prenatal genetics. As such, this book aims to be among the
largest and most useful references available. Named a Highly
Commended book in the Basic and Clinical Sciences by the British
Medical Association.
|
You may like...
Future City
Stephen Read, Jurgen Rosemann, …
Paperback
R1,998
Discovery Miles 19 980
|